Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      HomeBiotech

      Biotech

      Chinook Therapeutics Provides Business Update and Reports Second Quarter 2022 Financial Results
      Biotech

      Chinook Therapeutics Provides Business Update and Reports Second Quarter 2022 Financial Results

      August 9, 2022
      Celldex Reports Second Quarter 2022 Financial Results and Provides Corporate Update
      Biotech

      Celldex Reports Second Quarter 2022 Financial Results and Provides Corporate Update

      August 9, 2022
      Vaxcyte Reports Second Quarter 2022 Financial Results and Provides Business Update
      Biotech

      Vaxcyte Reports Second Quarter 2022 Financial Results and Provides Business Update

      August 9, 2022
      Prothena Reports Second Quarter 2022 Financial Results and Business Highlights
      Biotech

      Prothena Reports Second Quarter 2022 Financial Results and Business Highlights

      August 9, 2022
      Krystal Biotech Announces Second Quarter 2022 Financial Results and Reports Updates on Operational Progress
      Biotech

      Krystal Biotech Announces Second Quarter 2022 Financial Results and Reports Updates on Operational Progress

      August 9, 2022
      AAR’s corporate Safety Management System program recognized by FAA
      Industrials

      AAR’s corporate Safety Management System program recognized by FAA

      August 3, 2022
      Bionano Genomics Announces Publication of Landmark Research Study in Myelodysplastic Syndrome Showing OGM Data would Result in Revised Prognostic Risk Classification or Additional Actionable Variants in 28% of Study Participants
      Biotech

      Bionano Genomics Announces Publication of Landmark Research Study in Myelodysplastic Syndrome Showing OGM Data would Result in Revised Prognostic Risk Classification or Additional Actionable Variants in 28% of Study Participants

      August 2, 2022
      Krystal Biotech Announces FDA Acceptance of KB407 IND Application for Cystic Fibrosis Clinical Trial
      Biotech

      Krystal Biotech Announces FDA Acceptance of KB407 IND Application for Cystic Fibrosis Clinical Trial

      August 2, 2022
      Immunocore announces upcoming oral presentation of initial Phase 1 data of ImmTAC® candidate IMC-F106C targeting PRAME at European Society for Medical Oncology (ESMO) Congress 2022
      Biotech

      Immunocore announces upcoming oral presentation of initial Phase 1 data of ImmTAC® candidate IMC-F106C targeting PRAME at European Society for Medical Oncology (ESMO) Congress 2022

      August 2, 2022
      Recursion to Participate in Upcoming Investor Conference
      Biotech

      Recursion to Participate in Upcoming Investor Conference

      August 2, 2022
      « 1 … 120 121 122 123 124 … 134 »

       

      LATEST NEWS

      • Health Sanofi Market Potential Boosted by Amvuttra Data

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2026